Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

Unidad de Investigacion Medica en Epidemiologia Clinica

Status and phase: Completed; Phase 3

Conditions: Prediabetic State

Treatments: Dietary Supplement: Vanadyl sulfate; Other: Magnesium oxide

Study type: Interventional

Funder types: Other

Identifiers

NCT00561132

2002/252/129

173/03/13

FP-2003/073

Details and patient eligibility

About

The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.

Enrollment: 14 patients

Sex: All

Ages: 40 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of impaired glucose tolerance
• Body mass index from 25 to 35 kg/m2
• History of type 2 diabetes mellitus in the first branch

Exclusion criteria

• Taking medication with known effects on carbohydrate or insulin metabolism
• Thyroid diseases
• Hepatic diseases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

14 participants in 2 patient groups, including a placebo group

1

Experimental group

Treatment:

Dietary Supplement: Vanadyl sulfate

2

Placebo Comparator group

Treatment:

Other: Magnesium oxide